Opinion|Videos|January 9, 2024
Optimizing Drug Delivery Methods With Nanotechnologies
Author(s)Ascendia Pharma
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, highlights the benefits of the company’s nanotechnologies in supporting formulation development of poorly soluble molecules.
Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, discusses:
- Capabilities related to formulation development and manufacturing of cGMP batches
- Considerations in the development of formulations for poorly soluble molecules
- Role of nanotechnologies to optimize drug delivery methods, such as long-acting injectables
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FAQ: FDA’s Shifts in Pharma Regulation and Strategy in 2025
2
Multi-Compendial Compliance for Pharmaceutical Excipients–Part 1: A Practical Application of Specification Equivalence
3
Momentum and Automation Driving Pharma Innovation and Digitalization Through 2026
4
Johnson & Johnson’s Tecvayli Combo Wins FDA National Priority Voucher
5